Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Direct recognition of hepatocyte-expressed MHC class I alloantigens is required for tolerance induction
Moumita Paul-Heng, Mario Leong, Eithne Cunningham, Daniel L. J. Bunker, Katherine Bremner, Zane Wang, Chuanmin Wang, Szun Szun Tay, Claire McGuffog, Grant J. Logan, Ian E. Alexander, Min Hu, Stephen I. Alexander, Tim D. Sparwasser, Patrick Bertolino, David G. Bowen, G. Alex Bishop, Alexandra Sharland
Moumita Paul-Heng, Mario Leong, Eithne Cunningham, Daniel L. J. Bunker, Katherine Bremner, Zane Wang, Chuanmin Wang, Szun Szun Tay, Claire McGuffog, Grant J. Logan, Ian E. Alexander, Min Hu, Stephen I. Alexander, Tim D. Sparwasser, Patrick Bertolino, David G. Bowen, G. Alex Bishop, Alexandra Sharland
View: Text | PDF
Research Article Hepatology Transplantation

Direct recognition of hepatocyte-expressed MHC class I alloantigens is required for tolerance induction

  • Text
  • PDF
Abstract

Adeno-associated viral vector–mediated (AAV-mediated) expression of allogeneic major histocompatibility complex class I (MHC class I) in recipient liver induces donor-specific tolerance in mouse skin transplant models in which a class I allele (H-2Kb or H-2Kd) is mismatched between donor and recipient. Tolerance can be induced in mice primed by prior rejection of a donor-strain skin graft, as well as in naive recipients. Allogeneic MHC class I may be recognized by recipient T cells as an intact molecule (direct recognition) or may be processed and presented as an allogeneic peptide in the context of self-MHC (indirect recognition). The relative contributions of direct and indirect allorecognition to tolerance induction in this setting are unknown. Using hepatocyte-specific AAV vectors encoding WT allogeneic MHC class I molecules, or class I molecules containing a point mutation (D227K) that impedes direct recognition of intact allogeneic MHC class I by CD8+ T cells without hampering the presentation of processed peptides derived from allogeneic MHC class I, we show here that tolerance induction depends upon recognition of intact MHC class I. Indirect recognition alone yielded a modest prolongation of subsequent skin graft survival, attributable to the generation of CD4+ Tregs, but it was not sufficient to induce tolerance.

Authors

Moumita Paul-Heng, Mario Leong, Eithne Cunningham, Daniel L. J. Bunker, Katherine Bremner, Zane Wang, Chuanmin Wang, Szun Szun Tay, Claire McGuffog, Grant J. Logan, Ian E. Alexander, Min Hu, Stephen I. Alexander, Tim D. Sparwasser, Patrick Bertolino, David G. Bowen, G. Alex Bishop, Alexandra Sharland

×

Figure 6

Allogeneic skin graft tolerance induction requires recognition of intact donor MHC class I.

Options: View larger image (or click on image) Download as PowerPoint
Allogeneic skin graft tolerance induction requires recognition of intact...
(A) B10.BR mice were injected with 5 × 1011 vgc AAV-Kb (n = 6) or Kb-D227K (n = 6), or were not transduced (n = 16). Seven days later, mice received 178.3 skin grafts, which express Kb on an H-2k background. Statistical analysis of graft survival was carried out using the log-rank (Mantel-Cox) test. Modest graft survival prolongation was observed in mice transduced with AAV-Kb-D227K (MST 26 days vs. 16 days in uninjected controls, P = 0.0016), but tolerance was not achieved. Conversely, all mice inoculated with AAV-Kb accepted 178.3 skin grafts indefinitely (P = 0.0005 vs. Kb-D227K). (B) C57BL/6 mice received 5 × 1011 vgc AAV-Kd or Kd-D227K (n = 6 per group) or no vector (n = 12) and, after a further 7 days, were transplanted with B6.Kd skin (Kd-transgenic on an H-2b background). Survivals were analyzed as for A. Skin graft survival was increased to 28.5 days in mice transduced with AAV-Kd-D227K compared with 15 days in untransduced recipients (P = 0.001), but again, tolerance was not induced. All grafts survived beyond 100 days in mice transduced with AAV-Kd (P = 0.0005 vs. Kd-D227K).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts